SlowBull
The Business Brief TUESDAY, 1 SEPTEMBER 2026
← All stories
Markets

Medtronic’s Stars Are Aligning for a Price Recovery

1 source ·1 article ·7h ago

Medtronic beat Q1 FY2027 estimates, raised guidance, and holds a Moderate Buy rating from analysts, with its 3%-plus dividend positioning it near Dividend King status.

Covered by 1 outlet

Marketbeat 1

All coverage · 1 article

MarketBeat ·7h ago

Medtronic’s Stars Are Aligning for a Price Recovery

Medtronic beat Q1 FY2027 estimates, raised guidance, and holds a Moderate Buy rating from analysts, with its 3%-plus dividend positioning it near Dividend King status.